Pharmacists in Kingsland, Georgia


13 Pharmacists found in Kingsland
male pharmacist

Allan I Kart, RPH


Pharmacist
1351 Boone Avenue Ext E, Kingsland, GA 31548
912-729-6450    

male pharmacist

Dr. Arnold Edd Holland Iii, PHARMD


Pharmacist
1601 Hwy 40 E, Kingsland, GA 31548
912-729-1457    

female pharmacist

Cindy Rochelle Cambron


Pharmacist
111 Masters Way, Kingsland, GA 31548
912-293-1562    



male pharmacist

Dr. Darrell Maurice Lampkin, PHARM.D.


Pharmacist
1601 Ga Highway 40 E, Kingsland, GA 31548
912-729-1457    

male pharmacist

Mr. John D Michael, RPH


Pharmacist
1351 Boone Avenue Ext E, Kingsland, GA 31548
912-729-6450     912-729-4221

female pharmacist

Julia Louise Brand


Pharmacist
1402 Boone St, Kingsland, GA 31548
912-729-6227    

female pharmacist

Linah Amanda Neighbors, PHARMD


Pharmacist
2060 Hwy 40 E, Kingsland, GA 31548
912-673-9130    

female pharmacist

Misty Shay Campbell


Pharmacist
1601 Hwy 40 E, Kingsland, GA 31548
912-729-6170     912-729-7700

female pharmacist

Mrs. Molly Moncrieff, PHARM.D


Pharmacist
1351 Boone Ave Ext E, Kingsland, GA 31548
912-729-6450    

female pharmacist

Dr. Ryan Manning Clements


Pharmacist
1601 Hwy 40 E, Kingsland, GA 31548
912-729-1457    

female pharmacist

Mrs. Terri Lynn Shiels, RPH


Pharmacist
2060 Hwy 40 E, Kingsland, GA 31548
912-673-9130     912-673-9136

male pharmacist

Warren Driggers, PHARMD


Pharmacist
1390 Boone Ave Ext E, Kingsland, GA 31548
912-729-6450    

male pharmacist

Mr. William Joseph Tuttle Sr.


Pharmacist
1402 Boone St, Kingsland, GA 31548
912-729-6227    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.